PubRank

I M Macrae

Author PubWeight™ 33.65‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Estrogen as a neuroprotectant in stroke. J Cereb Blood Flow Metab 2000 2.03
2 Neuroprotection by a selective estrogen receptor beta agonist in a mouse model of global ischemia. Am J Physiol Heart Circ Physiol 2004 1.24
3 Ebselen protects both gray and white matter in a rodent model of focal cerebral ischemia. Stroke 2001 1.24
4 Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus. Nat Genet 1997 1.18
5 Estrogen status affects sensitivity to focal cerebral ischemia in stroke-prone spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2000 1.13
6 Influence of ischemia and reperfusion on the course of brain tissue swelling and blood-brain barrier permeability in a rodent model of transient focal cerebral ischemia. Exp Neurol 1997 1.03
7 Release of noradrenaline and dopamine by nerve stimulation in the guinea-pig and rat vas deferens. Br J Pharmacol 1984 1.02
8 Distribution of subgroups of noradrenaline neurons in the coeliac ganglion of the guinea-pig. Cell Tissue Res 1986 1.02
9 Brain aromatase expression after experimental stroke: topography and time course. J Steroid Biochem Mol Biol 2005 1.01
10 Characterization of the microglial response to cerebral ischemia in the stroke-prone spontaneously hypertensive rat. Hypertension 2001 0.98
11 Genetic and gender influences on sensitivity to focal cerebral ischemia in the stroke-prone spontaneously hypertensive rat. Hypertension 1999 0.98
12 Inhibition of nitric oxide synthesis does not reduce infarct volume in a rat model of focal cerebral ischaemia. Neurosci Lett 1992 0.98
13 Specific expression of the cell cycle regulation proteins, GADD34 and PCNA, in the peri-infarct zone after focal cerebral ischaemia in the rat. Eur J Neurosci 2002 0.92
14 Reduction of local cerebral blood flow to pathological levels by endothelin-1 applied to the middle cerebral artery in the rat. Neurosci Lett 1990 0.91
15 Susceptibility to cerebral infarction in the stroke-prone spontaneously hypertensive rat is inherited as a dominant trait. Stroke 1998 0.90
16 Impaired functional recovery after stroke in the stroke-prone spontaneously hypertensive rat. Stroke 2004 0.90
17 Investigation of estrogen status and increased stroke sensitivity on cerebral blood flow after a focal ischemic insult. J Cereb Blood Flow Metab 2000 0.90
18 The neuroprotective efficacy of ebselen (a glutathione peroxidase mimic) on brain damage induced by transient focal cerebral ischaemia in the rat. Neurosci Lett 1995 0.89
19 Neuroprotective efficacy of ebselen, an anti-oxidant with anti-inflammatory actions, in a rodent model of permanent middle cerebral artery occlusion. Br J Pharmacol 1997 0.88
20 The cardiovascular actions of clonidine and neuropeptide-Y in the ventrolateral medulla of the rat. Br J Pharmacol 1989 0.88
21 Reciprocal consomic strains to evaluate y chromosome effects. Hypertension 2001 0.86
22 Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia. Br J Pharmacol 1994 0.84
23 ESC-BRAIN: experimental and clinical stroke research--do they connect?. Meeting report of the ESC-BRAIN joint symposium held in London and Shanghai in May 2013. Cerebrovasc Dis 2013 0.83
24 Genes encoding atrial and brain natriuretic peptides as candidates for sensitivity to brain ischemia in stroke-prone hypertensive rats. Hypertension 1999 0.83
25 Endothelin, cerebral ischaemia and infarction. Clin Exp Hypertens 1995 0.82
26 Impaired cerebral autoregulation 24 h after induction of transient unilateral focal ischaemia in the rat. Eur J Neurosci 2000 0.81
27 Differences in inositol phosphate production in blood vessels of normotensive and spontaneously hypertensive rats. Br J Pharmacol 1991 0.81
28 Identification of the growth arrest and DNA damage protein GADD34 in the normal human heart and demonstration of alterations in expression following myocardial ischaemia. Int J Cardiol 2006 0.79
29 The selective oestrogen receptor modulator, LY362321, is not neuroprotective in a rat model of transient focal ischaemia. J Neuroendocrinol 2008 0.78
30 Topographic profile of reperfusion into MCA territory following endothelin-1-induced transient focal cerebral ischaemia. Neurosci Lett 1996 0.77
31 Midline B3 serotonin nerves in rat medulla are involved in hypotensive effect of methyldopa. J Cardiovasc Pharmacol 1986 0.77
32 Up-regulation of a growth arrest and DNA damage protein (GADD34) in the ischaemic human brain: implications for protein synthesis regulation and DNA repair. Neuropathol Appl Neurobiol 2004 0.76
33 New approaches to the study of bulbospinal (B3) serotonergic neurons in the control of blood pressure. J Hypertens Suppl 1985 0.76
34 Effect of neuropeptide Y on alpha 2-adrenoceptor-mediated cardiovascular responses in the pithed rat. Br J Pharmacol 1990 0.75
35 Reduction in local cerebral blood flow induced by endothelin-1 applied topically to the middle cerebral artery in the rat. J Cardiovasc Pharmacol 1991 0.75
36 The contractile response to and the release of noradrenaline by transmural nerve stimulation in the guinea-pig vas deferens and a comparison with the response to noradrenaline. Br J Pharmacol 1983 0.75
37 Neuropeptide Y-induced inositol phospholipid hydrolysis in blood vessels from normotensive and spontaneously hypertensive rats. Gen Pharmacol 1993 0.75
38 Autoradiographic evaluation of forskolin and D1 dopamine receptor binding in a rat model of focal cerebral ischaemia. Brain Res 1992 0.75
39 Effects of neuropeptide Y on forskolin, alpha 2- and beta-adrenoceptor-regulated cAMP levels in the rat brain slice. Peptides 1991 0.75
40 Cerebrovascular effects of NG-nitro-L-arginine methylester are conserved under halothane anaesthesia. Eur J Pharmacol 1993 0.75
41 Central cardiovascular effects of rilmenidine and neuropeptide Y in the conscious spontaneously hypertensive rat: haemodynamic and biochemical evidence for a negative interaction. J Cardiovasc Pharmacol 1992 0.75
42 Differential patterns of local cerebral glucose utilisation associated with rilmenidine- or B-HT 933-induced hypotension. Brain Res 1994 0.75
43 HMPAO as a regional cerebral blood flow tracer at high flow levels. J Nucl Med 1996 0.75
44 Consequences of transient focal cerebral ischaemia for second messenger and neurotransmitter binding in the rat: quantitative autoradiographic analysis of forskolin, dopamine D1 receptor binding and cerebral blood flow changes. Eur J Neurosci 1996 0.75